Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
HCA
Financials
Revenue by segment
HCA
HCA Healthcare, Inc.
Backtest
HCA
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Revenue
Revenue by segment
Net income
EPS
Cash flow
Balance sheet
Valuation
Shares and dividends
Costs
Revenue by segment
Annual
Quarterly
Revenue by segment
Annual
Quarterly
2025, ended Dec 31, 2025
American Group
$26.4B
35%
Atlantic Group
$24.7B
33%
National Group
$21.3B
28%
Corporate and Other
$3.2B
4%
Earlier:
Southwest Group
to 2010
Central Group
to 2010
Segments by fiscal year
CSV
Segments by fiscal year
USD
Line, in USD
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2014
2013
2012
2011
2010
2009
American Group
26.4B
24.7B
22.3B
20.9B
19.6B
23.6B
23.2B
22.0B
20.9B
19.7B
17.5B
16.5B
16.1B
13.7B
—
—
Atlantic Group
24.7B
23.4B
21.2B
19.3B
19.1B
—
—
—
—
—
—
—
—
—
—
—
National Group
21.3B
19.7B
18.1B
16.8B
16.3B
25.7B
25.9B
22.6B
20.8B
19.8B
17.3B
16.0B
15.5B
14.7B
11.6B
11.0B
Corporate and Other
3.17B
2.90B
3.38B
3.28B
3.69B
2.25B
2.25B
2.14B
1.93B
1.98B
2.06B
1.73B
1.39B
1.23B
0.98B
0.88B
Earlier (2)
—
—
—
—
—
—
—
—
—
—
—
—
—
—
15.4B
14.9B
Southwest Group
—
—
—
—
—
—
—
—
—
—
—
—
—
—
8.70B
8.28B
Central Group
—
—
—
—
—
—
—
—
—
—
—
—
—
—
6.73B
6.57B
Total
75.6B
70.6B
65.0B
60.2B
58.8B
51.5B
51.3B
46.7B
43.6B
41.5B
36.9B
34.2B
33.0B
29.7B
28.0B
26.8B
More HCA Healthcare financials
Revenue
Net income
EPS
Free cash flow
Cash flow statement
Balance sheet
Revenue at other companies
ILMN
Illumina, Inc.
NTRA
Natera, Inc.
ELV
Elevance Health, Inc.
HUM
Humana Inc.
REGN
Regeneron Pharmaceuticals, Inc.
AZN
AstraZeneca PLC
Tools
Return calculator